Clinical Trial Update: FAPI PET for Lung Fibrosis [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial evaluating FAPI PET imaging for interstitial lung disease and pulmonary fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Pneumonitis
• Hypersensitivity Pneumonitis
• Idiopathic Interstitial Pneumonia
• Idiopathic Interstitial Pneumonias
• Interstitial Lung Disease
• Pneumoconiosis
• Pulmonary Fibrosis
• Radiation Pneumonitis

Drugs mentioned

• FAPI PET (Fibroblast activation protein inhibitor PET imaging tracer)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Interstitial Lung Disease, Idiopathic Interstitial Pneumonias | EARLY_Phase 1 | Status: RECRUITING